UCB SA (UCBJF)
UCB Market Cap : 53.60B for May 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AgomAb Therapeutics NV | 524.49M |
| AstraZeneca PLC | 290.67B |
| ANI Pharmaceuticals, Inc. | 1.863B |
| Corcept Therapeutics, Inc. | 6.347B |
| Assertio Holdings, Inc. | 150.44M |
Market Cap Related Metrics
| PE Ratio | 30.68 |
| PS Ratio | 6.235 |
| PEG Ratio | 0.0800 |
| Price to Free Cash Flow | 27.35 |
| Price | 281.55 |
| Earnings Yield | 3.26% |
| PEGY Ratio | 0.0799 |
| Operating PE Ratio | 23.88 |
| Normalized PE Ratio | 30.21 |